CHRONIC GRAFT VERSUS HOST DISEASE
Clinical trials for CHRONIC GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a liquid form of a Graft-Versus-Host disease drug be as effective as the pill?
Disease control Not yet recruitingThis trial compares a liquid (oral suspension) form of the drug belumosudil with the standard tablet in healthy adult men. The goal is to see if the liquid version is absorbed by the body in the same way, which could offer a more convenient option for people with chronic graft-ve…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug safety trial offers hope for cGVHD patients in india
Disease control Not yet recruitingThis study tests the safety of a drug called belumosudil in 26 Indian patients aged 12 and older who have chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Participants take the drug for up to 24 weeks, and doctors monitor for side effects an…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can meditation tame the Long-Term side effects of a stem cell transplant?
Symptom relief Not yet recruitingThis trial tests whether a mindfulness-based stress reduction program — including group sessions and one-on-one coaching — can help people living with chronic graft-versus-host disease (cGVHD) manage symptoms like pain, anxiety, and poor sleep. cGVHD is a complication that can oc…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Blood test could predict chronic GVHD after transplant
Knowledge-focused Not yet recruitingThis study looks at blood samples from 1500 stem cell transplant patients to find markers that can predict chronic graft-versus-host disease (cGVHD), a serious complication. Researchers will use mass spectrometry to analyze proteins in the blood and combine this with patient data…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC